Steve Chatters

Steve Chatters has extensive experience in the field of clinical science and medical affairs, currently serving as the Executive Vice President of Regulatory, Medical and Quality Affairs at Oxford Gene Technology since July 2017. In this role, Steve oversees clinical development activities with a focus on Cytocell FISH products, ensuring alignment between scientific, medical, and corporate strategies. Previously, Steve was a Senior Product Manager at Cytocell Ltd, managing the pathology marketing team, and held positions as a Principal Clinical Scientist at both Great Ormond Street Hospital for Children NHS Foundation Trust and University College London Hospitals NHS Foundation Trust. Steve's early career includes experience as a Clinical Scientist at London North West Healthcare NHS Trust. Steve holds a Bachelor's Degree in Biotechnology from the University of Westminster.